Circadian Timing as a Systems-Level Regulator of Chronic Disease: Convergent Mechanisms in Metabolic, Mitochondrial, and Inflammatory Regulation

Chronic diseases such as type 2 diabetes, cardiovascular disease, and cancer are typically studied as distinct pathologies, yet recurrently exhibit mitochondrial dysfunction, oxidative imbalance, and low-grade inflammation [1-3]. This narrative review examines whether circadian disruption functions as a shared upstream constraint linking these convergent features across chronic disease. A structured literature review of 49 studies across major biomedical databases evaluated mechanistic, experimental, and human evidence for circadian regulation of mitochondrial, redox, and inflammatory processes. Circadian disruption was consistently associated with reduced rhythmic amplitude and loss of physiological coordination rather than complete loss of function. Controlled human protocols demonstrate that circadian misalignment alone, independent of sleep or diet, produces measurable cardiometabolic changes [8-10], while epidemiological data link chronic disruption to elevated cardiometabolic and cancer risk [11,12]. Individuals with type 2 diabetes show blunted mitochondrial gene-expression rhythmicity [28], and clock genes coordinate transcriptional, metabolic, and immune signaling at the cellular level [4,6,16,19,36]. Conversely, behavioral realignment strategies such as early time-restricted eating improve cardiometabolic outcomes without caloric restriction [30]. These findings support reframing chronic disease itself as a disruption of temporal organization rather than isolated pathway dysfunction, positioning circadian timing as a cross-cutting, modifiable regulator across the six pillars of lifestyle medicine: whole-food nutrition, stress management, regular physical activity, positive social connection, cessation of addictive substances, and restorative sleep.